Frontiers in Neuroscience (Jul 2021)
MRI Radiomic Signature of White Matter Hyperintensities Is Associated With Clinical Phenotypes
- Martin Bretzner,
- Martin Bretzner,
- Anna K. Bonkhoff,
- Markus D. Schirmer,
- Sungmin Hong,
- Adrian V. Dalca,
- Adrian V. Dalca,
- Adrian V. Dalca,
- Kathleen L. Donahue,
- Anne-Katrin Giese,
- Mark R. Etherton,
- Pamela M. Rist,
- Pamela M. Rist,
- Marco Nardin,
- Razvan Marinescu,
- Razvan Marinescu,
- Clinton Wang,
- Clinton Wang,
- Robert W. Regenhardt,
- Xavier Leclerc,
- Renaud Lopes,
- Renaud Lopes,
- Oscar R. Benavente,
- John W. Cole,
- Amanda Donatti,
- Christoph J. Griessenauer,
- Christoph J. Griessenauer,
- Laura Heitsch,
- Laura Heitsch,
- Lukas Holmegaard,
- Katarina Jood,
- Jordi Jimenez-Conde,
- Steven J. Kittner,
- Robin Lemmens,
- Robin Lemmens,
- Christopher R. Levi,
- Christopher R. Levi,
- Patrick F. McArdle,
- Caitrin W. McDonough,
- James F. Meschia,
- Chia-Ling Phuah,
- Arndt Rolfs,
- Stefan Ropele,
- Jonathan Rosand,
- Jaume Roquer,
- Tatjana Rundek,
- Ralph L. Sacco,
- Reinhold Schmidt,
- Pankaj Sharma,
- Pankaj Sharma,
- Agnieszka Slowik,
- Alessandro Sousa,
- Tara M. Stanne,
- Daniel Strbian,
- Turgut Tatlisumak,
- Turgut Tatlisumak,
- Vincent Thijs,
- Achala Vagal,
- Johan Wasselius,
- Johan Wasselius,
- Daniel Woo,
- Ona Wu,
- Ramin Zand,
- Bradford B. Worrall,
- Jane M. Maguire,
- Arne Lindgren,
- Arne Lindgren,
- Christina Jern,
- Polina Golland,
- Grégory Kuchcinski,
- Natalia S. Rost
Affiliations
- Martin Bretzner
- J. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, United States
- Martin Bretzner
- Inserm, CHU Lille, U1172 - LilNCog (JPARC) - Lille Neurosciences and Cognition, University of Lille, Lille, France
- Anna K. Bonkhoff
- J. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, United States
- Markus D. Schirmer
- J. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, United States
- Sungmin Hong
- J. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, United States
- Adrian V. Dalca
- J. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, United States
- Adrian V. Dalca
- A. A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
- Adrian V. Dalca
- Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA, United States
- Kathleen L. Donahue
- J. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, United States
- Anne-Katrin Giese
- J. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, United States
- Mark R. Etherton
- J. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, United States
- Pamela M. Rist
- J. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, United States
- Pamela M. Rist
- Division of Preventive Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, United States
- Marco Nardin
- J. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, United States
- Razvan Marinescu
- J. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, United States
- Razvan Marinescu
- Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA, United States
- Clinton Wang
- J. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, United States
- Clinton Wang
- Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA, United States
- Robert W. Regenhardt
- J. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, United States
- Xavier Leclerc
- Inserm, CHU Lille, U1172 - LilNCog (JPARC) - Lille Neurosciences and Cognition, University of Lille, Lille, France
- Renaud Lopes
- Inserm, CHU Lille, U1172 - LilNCog (JPARC) - Lille Neurosciences and Cognition, University of Lille, Lille, France
- Renaud Lopes
- CNRS, Institut Pasteur de Lille, US 41 - UMS 2014 - PLBS, Lille, France
- Oscar R. Benavente
- Department of Medicine, Division of Neurology, University of British Columbia, Vancouver, BC, Canada
- John W. Cole
- Department of Neurology, University of Maryland School of Medicine and Veterans Affairs Maryland Health Care System, Baltimore, MD, United States
- Amanda Donatti
- School of Medical Sciences, University of Campinas (UNICAMP) and the Brazilian Institute of Neuroscience and Neurotechnology (BRAINN), Campinas, Brazil
- Christoph J. Griessenauer
- 0Department of Neurosurgery, Geisinger, Danville, PA, United States
- Christoph J. Griessenauer
- 1Research Institute of Neurointervention, Paracelsus Medical University, Salzburg, Austria
- Laura Heitsch
- 2Division of Emergency Medicine, Washington University School of Medicine, St. Louis, MO, United States
- Laura Heitsch
- 3Department of Neurology, Washington University School of Medicine and Barnes-Jewish Hospital, St. Louis, MO, United States
- Lukas Holmegaard
- 4Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
- Katarina Jood
- 4Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
- Jordi Jimenez-Conde
- 5Department of Neurology, Neurovascular Research Group (NEUVAS), Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Universitat Autonoma de Barcelona, Barcelona, Spain
- Steven J. Kittner
- Department of Neurology, University of Maryland School of Medicine and Veterans Affairs Maryland Health Care System, Baltimore, MD, United States
- Robin Lemmens
- 6Department of Neurosciences, Experimental Neurology and Leuven Research Institute for Neuroscience and Disease (LIND), KU Leuven – University of Leuven, Leuven, Belgium
- Robin Lemmens
- 7VIB, Vesalius Research Center, Laboratory of Neurobiology, Department of Neurology, University Hospitals Leuven, Leuven, Belgium
- Christopher R. Levi
- 8School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia
- Christopher R. Levi
- 9Department of Neurology, John Hunter Hospital, Newcastle, NSW, Australia
- Patrick F. McArdle
- 0Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United States
- Caitrin W. McDonough
- 1Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, Gainesville, FL, United States
- James F. Meschia
- 2Department of Neurology, Mayo Clinic, Jacksonville, FL, United States
- Chia-Ling Phuah
- 3Department of Neurology, Washington University School of Medicine and Barnes-Jewish Hospital, St. Louis, MO, United States
- Arndt Rolfs
- 3Centogene AG, Rostock, Germany
- Stefan Ropele
- 4Department of Neurology, Clinical Division of Neurogeriatrics, Medical University of Graz, Graz, Austria
- Jonathan Rosand
- 5Henry and Allison McCance Center for Brain Health, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, United States
- Jaume Roquer
- 6Department of Neurology and Evelyn F. McKnight Brain Institute, Miller School of Medicine, University of Miami, Miami, FL, United States
- Tatjana Rundek
- 6Department of Neurology and Evelyn F. McKnight Brain Institute, Miller School of Medicine, University of Miami, Miami, FL, United States
- Ralph L. Sacco
- 6Department of Neurology and Evelyn F. McKnight Brain Institute, Miller School of Medicine, University of Miami, Miami, FL, United States
- Reinhold Schmidt
- 4Department of Neurology, Clinical Division of Neurogeriatrics, Medical University of Graz, Graz, Austria
- Pankaj Sharma
- 7Institute of Cardiovascular Research, Royal Holloway University of London (ICR2UL), Egham, United Kingdom
- Pankaj Sharma
- 8Ashford and St. Peter’s Hospitals, Chertsey and Ashford, United Kingdom
- Agnieszka Slowik
- 9Department of Neurology, Jagiellonian University Medical College, Krakow, Poland
- Alessandro Sousa
- Department of Neurology, University of Maryland School of Medicine and Veterans Affairs Maryland Health Care System, Baltimore, MD, United States
- Tara M. Stanne
- 4Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
- Daniel Strbian
- 0Division of Neurocritical Care and Emergency Neurology, Department of Neurology, Helsinki University Central Hospital, Helsinki, Finland
- Turgut Tatlisumak
- 1Department of Clinica Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
- Turgut Tatlisumak
- 2Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden
- Vincent Thijs
- 3Stroke Division, Florey Institute of Neuroscience and Mental Health, Department of Neurology Austin Health, Heidelberg, VIC, Australia
- Achala Vagal
- 4Department of Radiology, University of Cincinnati College of Medicine, Cincinnati, OH, United States
- Johan Wasselius
- 5Department of Clinical Sciences Lund, Radiology, Lund University, Lund, Sweden
- Johan Wasselius
- 6Department of Radiology, Neuroradiology, Skåne University Hospital, Malmö, Sweden
- Daniel Woo
- 7Department of Neurology and Rehabilitation Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, United States
- Ona Wu
- A. A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
- Ramin Zand
- 8Department of Neurology, Geisinger, Danville, PA, United States
- Bradford B. Worrall
- 9Department of Neurology and Public Health Sciences, University of Virginia, Charlottesville, VA, United States
- Jane M. Maguire
- 0Faculty of Health, University of Technology Sydney, Ultimo, NSW, Australia
- Arne Lindgren
- 1Department of Neurology and Rehabilitation Medicine, Skåne University Hospital, Lund, Sweden
- Arne Lindgren
- 2Department of Clinical Sciences Lund, Neurology, Lund University, Lund, Sweden
- Christina Jern
- 4Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
- Polina Golland
- Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA, United States
- Grégory Kuchcinski
- Inserm, CHU Lille, U1172 - LilNCog (JPARC) - Lille Neurosciences and Cognition, University of Lille, Lille, France
- Natalia S. Rost
- J. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, United States
- DOI
- https://doi.org/10.3389/fnins.2021.691244
- Journal volume & issue
-
Vol. 15
Abstract
ObjectiveNeuroimaging measurements of brain structural integrity are thought to be surrogates for brain health, but precise assessments require dedicated advanced image acquisitions. By means of quantitatively describing conventional images, radiomic analyses hold potential for evaluating brain health. We sought to: (1) evaluate radiomics to assess brain structural integrity by predicting white matter hyperintensities burdens (WMH) and (2) uncover associations between predictive radiomic features and clinical phenotypes.MethodsWe analyzed a multi-site cohort of 4,163 acute ischemic strokes (AIS) patients with T2-FLAIR MR images with total brain and WMH segmentations. Radiomic features were extracted from normal-appearing brain tissue (brain mask–WMH mask). Radiomics-based prediction of personalized WMH burden was done using ElasticNet linear regression. We built a radiomic signature of WMH with stable selected features predictive of WMH burden and then related this signature to clinical variables using canonical correlation analysis (CCA).ResultsRadiomic features were predictive of WMH burden (R2 = 0.855 ± 0.011). Seven pairs of canonical variates (CV) significantly correlated the radiomics signature of WMH and clinical traits with respective canonical correlations of 0.81, 0.65, 0.42, 0.24, 0.20, 0.15, and 0.15 (FDR-corrected p-valuesCV1–6 < 0.001, p-valueCV7 = 0.012). The clinical CV1 was mainly influenced by age, CV2 by sex, CV3 by history of smoking and diabetes, CV4 by hypertension, CV5 by atrial fibrillation (AF) and diabetes, CV6 by coronary artery disease (CAD), and CV7 by CAD and diabetes.ConclusionRadiomics extracted from T2-FLAIR images of AIS patients capture microstructural damage of the cerebral parenchyma and correlate with clinical phenotypes, suggesting different radiographical textural abnormalities per cardiovascular risk profile. Further research could evaluate radiomics to predict the progression of WMH and for the follow-up of stroke patients’ brain health.
Keywords